Health

News Hour: “In East Africa, life for the blind is paralysing. Many women are too poor to afford the bus fare to the clinic or hospital, or for a family member to stop work for a...

News Hour: Scientists in the United States have successfully treated broken spines and skulls in animals using 3D-printed synthetic bone, opening the possibility of future personalized bone implants for humans to fix dental, spinal other bone...

The world’s largest insulin maker, Novo Nordisk, is cutting 1,000 jobs as a part of a plan to reduce costs as it faces a challenging environment in 2017, especially in the large U.S. market, the company...

News Hour: Amgen Inc said on Tuesday its multiple myeloma drug, Kyprolis, did not fare better than Takeda Pharmaceutical Co Ltd’s older therapy Velcade in a study involving patients who had not yet been treated for...

News Hour: Giving stimulants to kids with attention deficit hyperactivity disorder (ADHD) may not help them complete homework or get better grades, a small study suggests. Researchers tested the effectiveness of medication against behavioral interventions in...

News Hour: Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar Therapeutics to treat multiple cancers. Opdivo, which competes with...

News Hour: Thailand is investigating four suspected cases of Zika-related microcephaly in three babies and a 36-week old unborn baby, the public health minister said on Tuesday, in what could be the first cases of Zika-linked...

News Hour: When little kids need to get a painful injection, music therapy can help them get through the procedure, a new study suggests. Children who received music therapy during a routine immunization visit were less...

News Hour: Novartis announced  that the US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris® (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes. Ilaris...

News Hour: Sandoz, the Novartis generic and biosimilar pharmaceutical division,  today announces the launch ofSandoz HACk – Healthcare Access Challenge – a global competition to generate innovative ideas and solutions to help tackle some of the...